Pergolini P - Search Results

1

Multicenter evaluation of five assays for myoglobin determination.

Zaninotto M, Pagani F, Altinier S, Amboni P, Bonora R, Dolci A, Pergolini P, Vernocchi A, Plebani M, Panteghini M. Zaninotto M, et al. Among authors: pergolini p. Clin Chem. 2000 Oct;46(10):1631-7. Clin Chem. 2000. PMID: 11017942

2

Structure-activity relationships of low molecular weight heparins expose to the risk of achieving inappropriate targets in patients with renal failure.

Stratta P, Karvela E, Canavese C, Quaglia M, Lazzarich E, Fenoglio R, Pergolini P, Bellomo G, Cena T, Magnani C. Stratta P, et al. Among authors: pergolini p. Curr Med Chem. 2009;16(23):3028-40. doi: 10.2174/092986709788803105. Curr Med Chem. 2009. PMID: 19689280 Review.

3

Estimating the cost of redundancy in molecular diagnostics: the case of activated protein C resistance and factor V Leiden.

Rolla R, Vidali M, Meola S, Pollarolo P, Pergolini P, Bellomo G. Rolla R, et al. Among authors: pergolini p. Clin Lab. 2011;57(9-10):711-7. Clin Lab. 2011. PMID: 22029186

4

Low-molecular-weight-heparin and pregnancy, when the dose does it: a nephrologist's opinion: a rebuttal.

Stratta P, Canavese C, Cena T, Quaglia M, Pergolini P, Bellomo G, Magnani C. Stratta P, et al. Among authors: pergolini p. J Thromb Haemost. 2011 Oct;9(10):2127-9; author reply 2129-30. doi: 10.1111/j.1538-7836.2011.04436.x. J Thromb Haemost. 2011. PMID: 21736699 Free article. No abstract available.

5

Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Barbieri L, Pergolini P, Verdoia M, Rolla R, Nardin M, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS). Barbieri L, et al. Among authors: pergolini p. Vascul Pharmacol. 2016 Apr;79:11-15. doi: 10.1016/j.vph.2015.10.006. Epub 2015 Oct 28. Vascul Pharmacol. 2016. PMID: 26518440

6

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions.

Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Sante Bongo A, Jaffe AS. Lupi A, et al. Among authors: pergolini p. EuroIntervention. 2016 Mar;11(12):1380-8. doi: 10.4244/EIJY14M11_04. EuroIntervention. 2016. PMID: 25405803 Free article.

7

Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.

Verdoia M, Pergolini P, Rolla R, Nardin M, Barbieri L, Schaffer A, Bellomo G, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS). Verdoia M, et al. Among authors: pergolini p. Cardiovasc Ther. 2016 Aug;34(4):209-15. doi: 10.1111/1755-5922.12188. Cardiovasc Ther. 2016. PMID: 27086085 Free article.

8

Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Verdoia M, Daffara V, Pergolini P, Rolla R, Marino P, Bellomo G, Carriero A, De Luca G; Novara Atherosclerosis Study Group (NAS). Verdoia M, et al. Among authors: pergolini p. Vascul Pharmacol. 2017 Aug;93-95:42-47. doi: 10.1016/j.vph.2017.04.001. Epub 2017 Apr 19. Vascul Pharmacol. 2017. PMID: 28433569

9

Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.

Sartori M, Andorno S, Pagliarulo M, Rigamonti C, Bozzola C, Pergolini P, Rolla R, Suno A, Boldorini R, Bellomo G, Albano E. Sartori M, et al. Among authors: pergolini p. Gut. 2007 May;56(5):693-8. doi: 10.1136/gut.2006.106641. Epub 2006 Nov 29. Gut. 2007. PMID: 17135308 Free PMC article.

10

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.

Nardin M, Verdoia M, Sartori C, Pergolini P, Rolla R, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group. Nardin M, et al. Among authors: pergolini p. J Cardiovasc Pharmacol. 2015 Oct;66(4):364-70. doi: 10.1097/FJC.0000000000000288. J Cardiovasc Pharmacol. 2015. PMID: 26065844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters